DJIA 16,807.69 -235.21 -1.38%
NASDAQ 4,422.24 -71.15 -1.58%
S&P 500 1,948.64 -23.65 -1.20%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

VGK, EFO: Big ETF Outflows

Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For

Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For An Unlikely Event

VEU, SRTY: Big ETF Inflows

Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors

Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 01, 2014

Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog

Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog

GlaxoSmithKline Needs Healthy Doses Of Good News Post China Scandal

Apple vs. Google: Which Tech Giant Will Conquer Healthcare?

Apple and Google are both expanding rapidly across the healthcare industry. Which company’s approach will conquer this highly fragmented market?

Switzerland's Prescription Drug Tactics Should Make Americans Jealous

Prescription drug costs in Switzerland are more than 40% lower than the U.S. on a per capita basis, yet the Swiss government is looking to lower those costs even further. Find out what benefits and risks could await its approach.

High Blood Pressure Is Most Prevalent in These 5 States

High blood pressure affects 67 million Americans and is a direct or contributing factor to roughly 1,000 deaths per day in the U.S. Find out what's being done to help combat this disease.
See More Articles...